2018 International Congress Archives - Page 4 of 177

1:45pm-3:15pm: A Physiotherapy Exercise Program for Parkinson’s Disease Patients with Impaired Gait and Postural Control

J. Yeung, A. Lau, E. Chan, J. Chung, L. Chan (Hong Kong)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A Preliminary Study of Cinnamomum verum on Anxiety, Locomotor Activity and Emotionality Behaviour in Wistar Albino Rats

N. Ahmed (Aligarh, India)

Clinical Trials and Therapy in Movement Disorders · Hall 3FG

1:45pm-3:15pm: A prospective MRI study of edema surrounding deep brain stimulation leads

L. Borellini, F. Cogiamanian, S. Sbaraini, E. Scola, G. Carrabba, M. Locatelli, S. Avignone, F. Mameli, F. Ruggiero, R. Ferrucci, G. Ardolino, S. Barbieri, P. Rampini (Milano, Italy)

Surgical Therapy: Parkinson's Disease · Hall 3FG

1:45pm-3:15pm: A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson’s disease

K.K. Chong, S.Y. Lim, M.A.A. A Manap, J.L. Lim, S.C. Low, S. K Mahadeva, A.H. Tan (Kuala Lumpur, Malaysia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration

T. Klopstock, F. Tricta, L. Neumayr, I. Karin, G. Zorzi, C. Fradette, T. Kmieć, B. Buechner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, P. Dušek, F. Zhao, F. Zibordi, N. Nardocci, C. Aguilar, S. Hayflick, M. Spino, A. Blamire, P. Hogarth, E. Vichinsky (Munich, Germany)

Rare Genetic and Metabolic Diseases · Hall 3FG

1:45pm-3:15pm: A Real-world Assessment of Hospitalizations Due to Falls among Patients with and without OFF episodes in Parkinson’s Disease

K. Rajagopalan, A. Lee, J. Barton, J. Pike (Marlborough, MA, USA)

Education in Movement Disorders · Hall 3FG

1:45pm-3:15pm: A single center retrospective analysis of Opicapone treatment in 90 Parkinson patients

M. Winterholler, H. Erxleben (Schwarzenbruck, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A study of correlation between screening tools for cognitive decline and gait status using three-dimensional gait analysis

PJ. Park (Busan, Republic of Korea)

Cognitive Disorders · Hall 3FG

1:45pm-3:15pm: A Study to Evaluate the Efficacy of PRX002/RG7935 in Participants With Early Parkinson’s Disease (PASADENA) – Study Design

B. Mollenhauer, F. Boess, K. Marek, W. Poewe, R. Postuma, K. Taylor, J. Dukart, M. Lindemann, L. Verselis, M. Niggli, T. Barata, A. Post, M. Koller, D. Ness, D. Selkoe, J. Sevigny (Göttingen, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG

1:45pm-3:15pm: A Virtual Reality Exercise Program Improves the Balance Function and Quality of Life of Patients with Parkinson’s Disease

G. Lee (Cheonan, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Hall 3FG